NCT02447705View on ClinicalTrials.gov

Replacement of Lamivudine by Telbivudine to Improve Renal Function

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Disorder Related to TransplantationVirus DiseasesInjury Due to Exposure to External Cause
Interventions
DRUG

telbivudine

telbivudine replace Lamivudine

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT02447705 - Replacement of Lamivudine by Telbivudine to Improve Renal Function | Biotech Hunter | Biotech Hunter